BD Launches innovative two-step disposable autoinjector

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

Hengrui Pharma and GSK Ink Agreement on 12 Innovative Drugs

In a recent move, Hengrui Pharma and GSK have...

Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA

Sino Biological US, Inc. proudly unveils ProPure™, an industry-leading...

Magnetic Particles Steer the Vesicles for Drug Delivery

Researchers have gone on to demonstrate that microscopic drug...

Becton, Dickinson and Company (BD) has launched the BD Intevia 1 mL two-step disposable autoinjector, a robust platform device combining autoinjector and pre-fillable syringe in one integrated system.

BD Launches BD Intevia 1 mL two-step disposable autoinjector – a robust platform device combining autoinjector and pre-fillable syringe in one integrated system.

The device is a 2-step push-on-skin device that is designed to effectively and safely inject a variety of drugs of different viscosities up to 35cP and different fill volumes up to 1mL. The unique design of BD Intevia 1 mL enables the pharmaceutical industry to adopt it for a variety of drugs without customizing the system components. Optimizing combination products can help avoid problems related to poorly integrated systems – such as breakage and incompatibility – that can occur when components are purchased from multiple suppliers. This, in turn, can support costs efficiency and improve time to market.

Peter Nolan, Worldwide President, BD Medical – Pharmaceutical Systems, said: “BD Intevia is a new generation of BD autoinjectors that will help drug manufacturers seamlessly enhance drug delivery experience.”

“For the patient, the platform technology is designed to promote patient ease of use when self-injecting, and it is supported by BD’s worldwide clinical injection expertise harnessing the latest research in drug delivery technology,” he added.

BD Intevia 1 mL disposable autoinjector rigorous patient-friendly design and control point feature enables simple two-step, push-on-skin activation allowing injection control by the patient. It is equipped with feedback indicators that visually show patients when the correct dose has been delivered and simultaneously triggers an audible click, providing the patient with an enhanced experience. These two considerations may enable patient treatment adherence.

In delivering a patient-centric solution, nine BD Intevia 1 mL disposable autoinjectors studies were conducted on a range of user population were evaluated. These focused on the device/user interface to identify and to eliminate or reduce the risk of use errors, so that BD Intevia 1 mL disposable autoinjector can be used safely. The latest validation study concluded that most participants are willing to use or switch to BD Intevia 1 mL disposable autoinjector. Study participants gave high ratings for key product attributes such as overall acceptance and confidence to control start of injection.

Latest stories

Related stories

Sarclisa by Sanofi has EC Approval to Treat Multiple Myeloma

In order to treat multiple myeloma in adults, Sarclisa...

Hengrui Pharma and GSK Ink Agreement on 12 Innovative Drugs

In a recent move, Hengrui Pharma and GSK have...

Sino Biological Sets New Industry Standard with ProPure™ Endotoxin-Free Proteins Made in the USA

Sino Biological US, Inc. proudly unveils ProPure™, an industry-leading...

Magnetic Particles Steer the Vesicles for Drug Delivery

Researchers have gone on to demonstrate that microscopic drug...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back